LH — LABCORP HOLDINGS INC.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 920148 ·
Last close
$368.24
Market Cap
$29.90B
52W High
$375.10
52W Low
$243.20
ADV30
714,216
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 3,731,100,000 | 1,112,000,000 | 456,700,000 | 298,700,000 | 18,532,300,000 | 141,800,000 | 9,909,100,000 |
| Mar 2026 | 3,537,600,000 | 1,013,800,000 | 387,200,000 | 277,800,000 | 19,087,100,000 | 981,100,000 | 10,341,600,000 |
| Dec 2025 | 3,515,800,000 | 993,200,000 | 382,000,000 | 164,700,000 | 18,392,700,000 | 532,300,000 | 9,756,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,638,400,000
Investing CF
$-1,452,200,000
Financing CF
$-689,300,000
CapEx
$-483,200,000
Dividends Paid
$-239,100,000
Buybacks
$-701,800,000
EPS Diluted TTM
$12.19
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$8,701,400,000
Inventory
$562,200,000
Receivables
$2,504,800,000
ST Investments
—
EBIT TTM
$1,460,900,000
Pretax Income TTM
$1,233,700,000
Interest Exp TTM
$227,200,000
Analysts
16
Yahoo Snapshot (yfinance, live)
Total Revenue
$14,594,499,584
EBITDA
$2,347,300,096
Free Cash Flow
$1,058,700,032
Enterprise Value
$35,875,069,952
Total Cash
$261,800,000
Total Debt
$6,775,900,160
Shares Out
81,200,000
Trailing EPS
$12.20
Book Value
$108.96
ROE
11.4%
ROA
5.5%
Div Yield
0.80%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,951,700,000 | 1,516,200,000 | 876,500,000 | 18,392,700,000 | 9,756,000,000 | 8,619,800,000 | 1,640,500,000 |
| Dec 2024 | 13,008,900,000 | 1,138,000,000 | 746,000,000 | 18,379,000,000 | 10,312,500,000 | 8,052,200,000 | 1,585,800,000 |
| Dec 2023 | 12,161,600,000 | 1,123,700,000 | 418,000,000 | 16,725,100,000 | 8,834,600,000 | 7,875,000,000 | 1,327,700,000 |
| Dec 2022 | 11,863,900,000 | 1,752,200,000 | 1,279,100,000 | 20,155,100,000 | 10,039,600,000 | 10,096,600,000 | 1,955,900,000 |
TTM Snapshot
Revenues TTM
$14,348,000,000
NetIncome TTM
$1,002,300,000
OpCashFlow TTM
—
Assets (Latest)
$18,532,300,000
Forward EPS
$19.56
Max Pain — expiry 2027-01-15
max pain strike: $290.00 · spot: $370.78 · call oi: 2,594 · put oi: 372
Expected Move to 2027-01-15:
±$28.40
(7.66%) —
implied range
$342.38 –
$399.18
· ATM straddle on $370.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DGX | QUEST DIAGNOSTICS INC | $28.29B | $256.35 | — |
| THC | TENET HEALTHCARE CORP | $22.45B | $282.07 | — |
| NTRA | Natera, Inc. | $41.68B | $287.47 | — |
| GH | Guardant Health, Inc. | $19.38B | $143.28 | — |
| BTSG | BrightSpring Health Services, Inc. | $13.90B | $69.83 | — |
News headlines (Yahoo Finance, 1h cache)
OTraces Selects Labcorp to Perform Biomarker Testing for Florida Department of Health–Funded Prostate Cancer Study
2026-11-18 13:30 · Yahoo
Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo Fleury
2026-11-17 21:30 · Yahoo
Clinical Trials Support Services - Global Strategic Business Report 2026: Capitalize on $15 Billion in New Revenue by 2032 as IQVIA, ICON, Labcorp, Parexel and Veeva Disrupt Trials with AI
2026-11-16 15:46 · Yahoo
Rare Disease Clinical Trials - Global Strategic Business Report 2026: Capitalize on the $19.5 Billion Market as IQVIA, ICON, Parexel, and Labcorp Disrupt Trial Economics by 2032
2026-11-16 15:44 · Yahoo
Labcorp (LH) Stock Sees Fair Value Lift After Q3 Analyst Target Increases
2026-11-14 14:11 · Yahoo
Labcorp (LH) Stock Looks About Right After Its Recent Run
2026-11-14 11:10 · Yahoo
Is Labcorp Holdings (LH) Still Cheap Following Its UBS Healthcare Conference Appearance?
2026-11-14 09:10 · Yahoo
Should Labcorp Stock Holders Look At Quest Diagnostics Instead?
2026-11-13 17:25 · Yahoo
Labcorp’s Lab Growth Surges as $125 Million Reimbursement Risk Looms
2026-11-13 16:14 · Yahoo
Labcorp: 3 Key Takeaways for Long-Term Investors
2026-11-13 00:41 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.